Beckley Psytech
Chandni Hindocha, Ph.D., currently serves as Associate Director of Clinical Development at Beckley Psytech, spearheading the advancement of clinical research for treatment-resistant depression and alcohol use disorder, including oversight of multiple successful phase 2 studies. Previously, at Jazz Pharmaceuticals, Chandni held dual roles as Associate Director in Clinical Development focusing on neuroscience and in Medical Affairs, contributing significantly to international clinical trial protocols and delivering extensive medical education in cannabinoid science. Chandni's academic background includes a Ph.D. in Psychopharmacology from UCL and substantial research experience in neuropsychopharmacology and addiction treatments, complemented by a strong history of scientific documentation and grant writing.
This person is not in any teams
This person is not in any offices